University of Oxford

Open Data about the University of Oxford

data.ox.ac.uk

beta

Data.ox is deprecated. Advanced notice of its end of life date will be advised in due course via this site and the ITSS mail list.

Vacancies within Nuffield Department of Surgical Sciences

There are currently 2 vacancies within Nuffield Department of Surgical Sciences:

Title Closes Salary
Postdoctoral Researcher in Cellular Therapeutics May 10, 2024, noon Standard Grade 7: £36,024 - £44,263 per annum
Trial Coordinator – DISCUS and Trans-EndoNET May 21, 2024, noon Standard Grade 6: £32,332 - £38,205 per annum

Postdoctoral Researcher in Cellular Therapeutics

Closes: May 10, 2024, noon; salary: Standard Grade 7: £36,024 - £44,263 per annum

<div> <p></p><div><strong>Contract type:</strong> <strong>Fixed-term contract until 30th June 2026</strong></div><br> <div><strong>Hours: Full-time</strong></div><br> <div>&#160;</div><br> <div><strong>About the role</strong></div><br> <div>We are looking for a postdoctoral researcher to work in Translational Research Immunology Group (TRIG) on translational, collaborative project funded by EU.&#160; You will be placed in the Institute of Developmental and Regenerative Medicine on the Old Road Campus working in a close collaboration with the Oxford Kidney Pathology group.</div><br> <div>&#160;</div><br> <div>You will be part of a bigger EU-funded project which goal is to develop a safe and efficient cell therapy based on genome edited T cells for IgA nephropathy (IgAN). IgAN is the most common glomerulonephritis; IgA-rich complexes are deposited in renal glomeruli, leading to renal failure a third of cases, but there are currently no effective treatments, so this an area of significant unmet need. Redirected T cells offer the potential to specifically target pathogenic IgA1 producing cells.</div><br> <div>&#160;</div><br> <div>You will work closely with members of TRIG and Oxford Kidney Pathology groups, including students, other post-docs and research assistants as well as international collaborators within the EU consortium.&#160; You will be responsible for testing T cell therapeutics developed by our consortium, using in vivo models of glomerular immune complex disease as well as the establishment of a novel model for IgA Nephropathy.&#160; Additionally, you will contribute to spatial transcriptomics and proteomics in human IgAN kidney samples.</div><br> <div>&#160;</div><br> <div><strong>About you</strong></div><br> <div>You will hold a PhD (or be near to completion: thesis submitted) in a relevant area at the time of application and will have extensive experience in immunology or kidney disease field.&#160; Experience with cell culture techniques, animal models, molecular techniques is required.&#160; . You will have demonstrated the ability to work independently within projects, with the ability to communicate results clearly and succinctly in presentations, manuscripts and grant applications.&#160; Experience with flow cytometry and genetic editing techniques as well as knowledge of kidney disease are desirable.</div><br> <div>&#160;</div><br> <div>This full-time post is available immediately and is fixed-term until June 2026 in the first instance.</div><br> <div>&#160;</div><br> <div><strong>Application Process</strong></div><br> <div>If you would like to discuss this role, please contact Fadi Issa, fadi.issa@nds.ox.ac.uk.</div><br> <div>&#160;</div><br> <div>Applications for this vacancy are to be made online. You will be required to upload a supporting statement, setting out how you meet the selection criteria, curriculum vitae and the names and contact details of two referees as part of your online application. Please quote reference <strong>NDSA926</strong> on all correspondence.</div><br> <div>&#160;</div><br> <div>Only applications received before <strong>noon 10 May 2024</strong> can be considered.</div><br> <div>&#160;</div><br> <div>Interviews will be held on Friday 24 May 2024.</div><br> <div>&#160;</div><br> <div><strong>Committed to equality and valuing diversity</strong></div> </div>

Trial Coordinator – DISCUS and Trans-EndoNET

Closes: May 21, 2024, noon; salary: Standard Grade 6: £32,332 - £38,205 per annum

<div> <p></p><div><strong>Contract type: Fixed term until 02 January 2025</strong></div><br> <div><strong>Hours: Full-time</strong></div><br> <div>&#160;</div><br> <div><strong>About the role</strong></div><br> <div>We are looking for an enthusiastic Clinical Trial Coordinator to join the Surgical Intervention Trials Unit (SITU), working within a multi-disciplinary environment in order to develop, implement and run clinical trial activities. You will be based at the Botnar Research Centre in Headington, Oxford but you will be able to agree a pattern of regular remote working with your line manager.</div><br> <div>&#160;</div><br> <div>The Clinical Trial Coordinator will join the established Trial Management Team within SITU, supporting the activities of the clinical trials and working closely with trial managers and data managers. This post will involve ensuring the effective conduct of the study in accordance with the trial protocol and regulatory and institutional procedures where appropriate. You will manage the trial email account, maintain trial files and will help manage activities of the participating clinical centres, which may include conducting site visits and addressing training needs where appropriate.</div><br> <div>&#160;</div><br> <div><strong>About you</strong>&#160;</div><br> <div>The successful candidate will be educated to A level or equivalent in English, Maths and a Science related subject. You will have previous experience in clinical research and working knowledge of the relevant ethical, legislative and research governance requirements relevant to clinical trials as well as familiarity with medical terminology. Excellent communication skills are essential as well as good organisational and problem-solving skills. You will have excellent communication and interpersonal skills with the ability to self-motivate and work well within a team environment. A willingness to travel to trial sites and meetings nationally is essential.</div><br> <div>&#160;</div><br> <div>This full-time post is available immediately and is fixed-term until 2nd January 2025 in the first instance. We would be willing to consider applications for part-time hours.&#160;</div><br> <div>&#160;</div><br> <div><strong>Application Process</strong></div><br> <div>If you would like to discuss this role, please contact the NDS SITU Operational Lead, Amy Taylor at op.lead@nds.ox.ac.uk</div><br> <div>&#160;</div><br> <div>Applications for this vacancy are to be made online. You will be required to upload a supporting statement, setting out how you meet the selection criteria, curriculum vitae and the names and contact details of two referees as part of your online application. Please quote reference NDSA930 on all correspondence.&#160;</div><br> <div>&#160;</div><br> <div>Only applications received before noon Tuesday 21st May 2024 can be considered.</div><br> <div>&#160;</div><br> <div>Interviews will be held on Thursday 30th May 2024.</div><br> <div>&#160;</div><br> <div><strong>Committed to equality and valuing diversity</strong></div> </div>